Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
October 9, 2008
 
Industry Categories  
News by Country  
News by MSA  
Today's News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for June 19, 2002 Subscribe to this News Feed    
 

REJUVENA TEAMS WITH INTERNATIONALLY ACCLAIMED CELL BIOLOGIST TO LAUNCH PSORIASIS, SKIN DISEASE CREAM

New skin care product successfully treats psoriasis and other skin diseases.

FORT WORTH, Texas (PRWEB) June 19, 2002
renowned cell biologist Dr. Lorraine Meisner to market a line of skin care products
to successfully treat psoriasis and other skin diseases.

Miraderm Psoriasis Cream is a patent-pending, nonprescription topical lotion that
has been proven to treat psoriasis in clinical trials. Miraderm is also effective in
treating eczema, dermatitis, dandruff, seborrheic dermatitis and inflammatory skin
lesions. Other products will be available soon.

Were excited to introduce this cream internationally to the millions of people who
suffer from the agonizing symptoms of psoriasis," said Brenda Warren, principal of
Rejuvena Distribution, the exclusive distributor for Miraderm. Miraderm Psoriasis
Cream has produced dramatic improvement in patients who have had limited or no
success with other treatments -- and it has none of the usual side effects."

Dr. Lorraine Meisner is a pioneer of vitamin C anti-aging creams, and her anti-aging
products are sold worldwide. Dr. Meisner has been a professor at the University of
Wisconsin -- Madison Medical School since 1968. She has held other positions at
prestigious institutions such as Stanford University, Dept. of Medicine; University of
Virginia Medical School; Cancer Research Institute in Boston; and Chief, Cytogenics
Section of the State Laboratory of Hygiene (Wisconsin). Miraderm Psoriasis Cream
is her latest invention. The cream combines the rigors of science and research with
the use of natural products to provide relief for red, itchy skin.

With most therapies for psoriasis there are severe side effects," Dr. Meisner said.
Some may cause cancer and others cause skin to thin out. Most products work
because they shut down the immune system. Miraderm Psoriasis Cream doesnt do
that. It has a natural, herbal base. I dont like to mess with Mother Nature."

Psoriasis is a chronic skin disorder that is believed to be related to the immune
system, though the cause is still unknown. It is not contagious; a person cannot
catch" psoriasis from another person. No cure has been found for psoriasis.

Miraderm Psoriasis Cream can be used frequently, as opposed to a steroid,"
Meisner said. And once it goes away, you dont have to use the cream anymore.
With steroids, as soon as you stop, the psoriasis comes back. Miraderm peels the
psoriasis off so that the skin can do its work and heal itself."

Rejuvena has launched its Web site (www.rejuvena.net) as an informational
clearinghouse on psoriasis and other skin diseases. Miraderm Psoriasis Cream sells
for $22.95 for a 50 ml tube or $39.95 for a 100 ml tube. Volume discounts are
available. Contact Rejuvena toll free at 1-866-Miraderm (1-866-647-2336).

# # #

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Steve Roth
InterStar Marketing & Public Relations
817-332-6522
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright